Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel

Paul A. Feldman, Jordan Steinberg, Ralph Madeb, Guy Bar, Ofer Nativ, Joseph Tal, Isaac Srugo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Background: Seroepidemeliogic surveys have provided valuable information on the prevalence and incidence of herpes simplex virus-2 infection in general and in selected populations. Objective: To review the reliability of traditional diagnostic approaches in herpes simplex virus-2 infection. Methods: In this cross-sectional study, 472 patients attending a clinic for sexually transmitted disease in 1998-1999 were evaluated for HSV-2 infection through collection of epidemiologic and clinical data. HSV-2 infection was confirmed by the presence of specific viral glycoprotein, gG-2, antibody in sera. Results: The seroprevalence of HSV-2 among clinic attendees was 9.33%. Of these attendees only 22% presented with or reported a history of typical vesicular lesions in the genital area. Infection rate was higher in patients with multiple sex partners (20.8% vs. 8.7%, P ≤ 0.0023), in individuals aged 30 or older (12.6 vs. 6.4%, P = 0.03) and in the Israeli Jewish population as compared to the Israeli Arab population (11.1% vs. 2.4%, P ≤ 0.01). Females with multiple sex partners exhibited higher rates of infection than did their male counterparts (50 vs. 16.1%, P ≤ 0.0275). Conclusion: The findings support the need for HSV-2 serologic testing in patients presenting to STD clinics even when typical genital lesions are not evident but where risk factors for HSV-2 infection are identified.

Original languageEnglish
Pages (from-to)626-628
Number of pages3
JournalIsrael Medical Association Journal
Volume5
Issue number9
StatePublished - Sep 1 2003
Externally publishedYes

Fingerprint

Human Herpesvirus 2
Israel
Sexually Transmitted Diseases
Viruses
Glycoproteins
Antibodies
Infection
Sexual Partners
Virus Diseases
Testing
Population
Seroepidemiologic Studies
Cross-Sectional Studies
Incidence
Serum

Keywords

  • Antibody
  • Glycoprotein
  • Herpes simplex virus
  • Infection
  • Sexually transmitted disease

ASJC Scopus subject areas

  • Medicine(all)
  • Bioengineering

Cite this

Feldman, P. A., Steinberg, J., Madeb, R., Bar, G., Nativ, O., Tal, J., & Srugo, I. (2003). Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel. Israel Medical Association Journal, 5(9), 626-628.

Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel. / Feldman, Paul A.; Steinberg, Jordan; Madeb, Ralph; Bar, Guy; Nativ, Ofer; Tal, Joseph; Srugo, Isaac.

In: Israel Medical Association Journal, Vol. 5, No. 9, 01.09.2003, p. 626-628.

Research output: Contribution to journalArticle

Feldman, PA, Steinberg, J, Madeb, R, Bar, G, Nativ, O, Tal, J & Srugo, I 2003, 'Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel', Israel Medical Association Journal, vol. 5, no. 9, pp. 626-628.
Feldman PA, Steinberg J, Madeb R, Bar G, Nativ O, Tal J et al. Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel. Israel Medical Association Journal. 2003 Sep 1;5(9):626-628.
Feldman, Paul A. ; Steinberg, Jordan ; Madeb, Ralph ; Bar, Guy ; Nativ, Ofer ; Tal, Joseph ; Srugo, Isaac. / Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel. In: Israel Medical Association Journal. 2003 ; Vol. 5, No. 9. pp. 626-628.
@article{bb43adf66f6047ec8b3859a964d1bf05,
title = "Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel",
abstract = "Background: Seroepidemeliogic surveys have provided valuable information on the prevalence and incidence of herpes simplex virus-2 infection in general and in selected populations. Objective: To review the reliability of traditional diagnostic approaches in herpes simplex virus-2 infection. Methods: In this cross-sectional study, 472 patients attending a clinic for sexually transmitted disease in 1998-1999 were evaluated for HSV-2 infection through collection of epidemiologic and clinical data. HSV-2 infection was confirmed by the presence of specific viral glycoprotein, gG-2, antibody in sera. Results: The seroprevalence of HSV-2 among clinic attendees was 9.33{\%}. Of these attendees only 22{\%} presented with or reported a history of typical vesicular lesions in the genital area. Infection rate was higher in patients with multiple sex partners (20.8{\%} vs. 8.7{\%}, P ≤ 0.0023), in individuals aged 30 or older (12.6 vs. 6.4{\%}, P = 0.03) and in the Israeli Jewish population as compared to the Israeli Arab population (11.1{\%} vs. 2.4{\%}, P ≤ 0.01). Females with multiple sex partners exhibited higher rates of infection than did their male counterparts (50 vs. 16.1{\%}, P ≤ 0.0275). Conclusion: The findings support the need for HSV-2 serologic testing in patients presenting to STD clinics even when typical genital lesions are not evident but where risk factors for HSV-2 infection are identified.",
keywords = "Antibody, Glycoprotein, Herpes simplex virus, Infection, Sexually transmitted disease",
author = "Feldman, {Paul A.} and Jordan Steinberg and Ralph Madeb and Guy Bar and Ofer Nativ and Joseph Tal and Isaac Srugo",
year = "2003",
month = "9",
day = "1",
language = "English",
volume = "5",
pages = "626--628",
journal = "Israel Medical Association Journal",
issn = "1565-1088",
publisher = "Israel Medical Association",
number = "9",

}

TY - JOUR

T1 - Herpes simplex virus type 2 seropositivity in a sexually transmitted disease clinic in Israel

AU - Feldman, Paul A.

AU - Steinberg, Jordan

AU - Madeb, Ralph

AU - Bar, Guy

AU - Nativ, Ofer

AU - Tal, Joseph

AU - Srugo, Isaac

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Background: Seroepidemeliogic surveys have provided valuable information on the prevalence and incidence of herpes simplex virus-2 infection in general and in selected populations. Objective: To review the reliability of traditional diagnostic approaches in herpes simplex virus-2 infection. Methods: In this cross-sectional study, 472 patients attending a clinic for sexually transmitted disease in 1998-1999 were evaluated for HSV-2 infection through collection of epidemiologic and clinical data. HSV-2 infection was confirmed by the presence of specific viral glycoprotein, gG-2, antibody in sera. Results: The seroprevalence of HSV-2 among clinic attendees was 9.33%. Of these attendees only 22% presented with or reported a history of typical vesicular lesions in the genital area. Infection rate was higher in patients with multiple sex partners (20.8% vs. 8.7%, P ≤ 0.0023), in individuals aged 30 or older (12.6 vs. 6.4%, P = 0.03) and in the Israeli Jewish population as compared to the Israeli Arab population (11.1% vs. 2.4%, P ≤ 0.01). Females with multiple sex partners exhibited higher rates of infection than did their male counterparts (50 vs. 16.1%, P ≤ 0.0275). Conclusion: The findings support the need for HSV-2 serologic testing in patients presenting to STD clinics even when typical genital lesions are not evident but where risk factors for HSV-2 infection are identified.

AB - Background: Seroepidemeliogic surveys have provided valuable information on the prevalence and incidence of herpes simplex virus-2 infection in general and in selected populations. Objective: To review the reliability of traditional diagnostic approaches in herpes simplex virus-2 infection. Methods: In this cross-sectional study, 472 patients attending a clinic for sexually transmitted disease in 1998-1999 were evaluated for HSV-2 infection through collection of epidemiologic and clinical data. HSV-2 infection was confirmed by the presence of specific viral glycoprotein, gG-2, antibody in sera. Results: The seroprevalence of HSV-2 among clinic attendees was 9.33%. Of these attendees only 22% presented with or reported a history of typical vesicular lesions in the genital area. Infection rate was higher in patients with multiple sex partners (20.8% vs. 8.7%, P ≤ 0.0023), in individuals aged 30 or older (12.6 vs. 6.4%, P = 0.03) and in the Israeli Jewish population as compared to the Israeli Arab population (11.1% vs. 2.4%, P ≤ 0.01). Females with multiple sex partners exhibited higher rates of infection than did their male counterparts (50 vs. 16.1%, P ≤ 0.0275). Conclusion: The findings support the need for HSV-2 serologic testing in patients presenting to STD clinics even when typical genital lesions are not evident but where risk factors for HSV-2 infection are identified.

KW - Antibody

KW - Glycoprotein

KW - Herpes simplex virus

KW - Infection

KW - Sexually transmitted disease

UR - http://www.scopus.com/inward/record.url?scp=0141794101&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141794101&partnerID=8YFLogxK

M3 - Article

C2 - 14509150

AN - SCOPUS:0141794101

VL - 5

SP - 626

EP - 628

JO - Israel Medical Association Journal

JF - Israel Medical Association Journal

SN - 1565-1088

IS - 9

ER -